Weave Bio
Silver
Information
Weave Bio is the company behind the Weave Platform, an AI-native regulatory automation management solution transforming how regulatory dossiers are managed. Designed for pharmaceutical companies, biotech firms, CROs, and regulatory consultants, the Weave Platform streamlines document preparation and regulatory lifecycle management. It automates initial draft creation, extracts key insights, and seamlessly integrates study data into an AI-powered regulatory workflow.
The platform accelerates regulatory timelines, improves review quality, and ensures compliance with global regulatory standards. AutoIND, a widely adopted solution for preclinical IND preparation, has earned industry recognition, including the “Biotech AI Innovation of the Year” award. Expanding into clinical-stage submissions, AutoCT builds upon Weave’s foundation, creating a comprehensive AI workbench for the entire therapy lifecycle.
Backed by leading AI and life sciences investors, Weave is shaping the future of regulatory automation with an AI-driven, human-powered approach, enhancing efficiency, regulatory quality, and cost-effectiveness.